BioVision Introduces EZSolution™ "ready-to-use" Inhibitors
|BioVision recently introduced a number of EZSolution™ Inhibitors that should be very useful for researchers studying key Signal Transduction Pathways such as GSK-3 signaling, MAP Kinase signaling, PI3-K/Akt/mTOR signaling, etc.|
FOR IMMEDIATE RELEASE
BioVision, Inc. is a privately held Life Science company headquartered in the beautiful San Francisco Bay area. BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other innovative research tools for studying Apoptosis, Metabolism, Cell Proliferation, Cellular Stress, Cell Damage and Repair, Diabetes, Obesity and Metabolic Syndrome, Stem Cell Biology, Gene Regulation, Signal Transduction, and more.